ReviewInternational urology and nephrology2023

The protective effects of SGLT-2 inhibitors, GLP-1 receptor agonists, and RAAS blockers against renal injury in patients with type 2 diabetes.

Zengguang Kuang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.